Cardura
Product Images NDC 0049-2750

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Cardura (NDC 0049-2750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cardura 01)

Chemical structure diagram showing the molecular structure of the active ingredient in Cardura, including aromatic rings, heterocyclic components, and functional groups consistent with the compound's chemistry.*

FDA Label Image

Table 3 (Cardura 02)

A chart and bar graph presenting effectiveness data from placebo-controlled trials of Cardura in different doses (4 mg and 8 mg). The table shows symptom score and maximum flow rate changes, with Cardura groups generally showing greater improvements over placebo. The bar graph highlights maximum flow rate differences across treatments in Study 2.*

FDA Label Image

Figure 1 (Study 1)

Two line graphs showing data from a 14-week study comparing Cardura to placebo. The left graph illustrates mean change in total symptom score from baseline over time, showing greater symptom improvement with Cardura. The right graph depicts mean increase in maximum urinary flow rate from baseline, indicating higher flow rates for Cardura versus placebo. Both graphs include error bars and sample sizes (N=50 for Cardura, N=47 for placebo).*

FDA Label Image

Pfizer (Cardura 04)

FDA Label Image

Cardura 04a

FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Cardura 1 mg tablets label showing the active ingredient doxazosin mesylate. The label indicates a package of 100 tablets, with storage instructions at 25°C (77°F) and dosage information referencing accompanying prescribing information. The labeler is Roerig, a division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (2 mg Tablet Bottle Label)

Cardura 2 mg tablets label showing doxazosin mesylate as the active ingredient. The label includes storage instructions at 25°C with permitted excursions, a barcode with NDC 0049-2760-66, and states a package count of 100 tablets. It is labeled as Rx only and distributed by Roerig, a division of Pfizer Inc., NY, NY.*

FDA Label Image

Principal Display Panel (4 mg Tablet Bottle Label)

Label for Cardura 4 mg tablets containing doxazosin mesylate, manufactured by Roerig, a division of Pfizer Inc. The label indicates a package size of 100 tablets and includes storage instructions to keep at 25°C (77°F) with permitted excursions. The label also provides dosage use directions and specifies the product is for prescription use only.*

FDA Label Image

Principal Display Panel (8 mg Tablet Bottle Label)

Label for Cardura 8 mg tablets (doxazosin mesylate) by Roerig, showing medication strength prominently. The label includes storage instructions, dosage note, tablet count of 100, Rx only designation, Pfizer branding, and product identification codes including NDC 0049-2780-66.*

FDA Label Image

Cardura 09

Cardura 1 mg tablets packaging label by ROERIG, showing the active ingredient doxazosin. The label includes storage instructions, dosage information, and manufacturer details. The package contains 100 tablets, with the product registered under NDC 0049-2410-10.*

FDA Label Image

Cardura 10

Cardura 2 mg tablets packaging label showing the active ingredient doxazosin. The label includes storage instructions, recommended dosage reference, and states the product contains doxazosin mesylate equivalent to 2 mg doxazosin as a free base. It also notes the product is made in Singapore and distributed by Roerig, a division of Pfizer Inc. The package contains 100 tablets and is labeled Rx only.*

FDA Label Image

Cardura 11

Cardura 4 mg tablets label showing active ingredient doxazosin mesylate. The label states 100 tablets per package and highlights storage conditions and dosage information. The product is distributed by Roerig, a division of Pfizer Inc. The label includes the NDC 0049-2614-10 and mentions the tablets are Rx only.*

FDA Label Image

Cardura 12

Label for Cardura (doxazosin) tablets, 8 mg strength, distributed by Roerig, a division of Pfizer Inc. The label indicates storage at 25°C (77°F) with permitted excursions, contains 100 tablets, and displays the NDC 0049-2716-10. The label includes dosage form and strength, with prescription-only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.